Identification of Bioactive Peptides with Α-Amylase Inhibitory Potential from Enzymatic Protein Hydrolysates of Red Seaweed (porphyra Spp).

Habtamu Admassu,Mohammed A. A. Gasmalla,Ruijin Yang,Wei Zhao
DOI: https://doi.org/10.1021/acs.jafc.8b00960
IF: 6.1
2018-01-01
Journal of Agricultural and Food Chemistry
Abstract:Inhibition of α-amylase enzyme is one therapeutic approach in lowering glucose level in the blood to manage diabetes mellitus. In this study α-amylase inhibitory peptides were identified from proteolytic enzymes hydrolysates of red seaweed laver ( Porphyra species) using consecutive chromatographic techniques. In the resultant fractions from RP-HPLC (D1-10), D2 inhibited α-amylase activity (88.67 ± 1.05%) significantly ( p ≤ 0.5) at 1 mg/mL protein concentration. A mass spectrometry (ESI-Q-TOF- MS) analysis was used to identify peptides from this fraction. Two novel peptides were identified as Gly-Gly-Ser-Lys and Glu-Leu-Ser. To validate their α-amylase inhibitory activity, these peptides were synthesized chemically. The peptides were demonstrated inhibitory activity at IC50 value: 2.58 ± 0.08 mM (Gly-Gly-Ser-Lys) and 2.62 ± 0.05 mM (Glu-Leu-Ser). The inhibitory kinetics revealed that these peptides exhibited noncompetitive binding mode. Thus, laver can be a potential source of novel ingredients in food and pharmaceuticals in diabetes mellitus management.
What problem does this paper attempt to address?